###### Strengths and limitations of this study

-   This is the first systematic review specifically studying the impact of early sedation depth on patient important outcomes.

-   In preparation of this protocol we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols guidelines, and our study is registered with the international prospective register of systematic reviews (PROSPERO).

-   Our robust search strategy will decrease our risk of missing relevant studies.

-   Our inclusion of non-randomised trials increases the risk of study bias.

Introduction {#s1}
============

Mechanical ventilation is a common intervention in critically ill patients.[@R1] There is increasing recognition that the management of non-ventilator-related aspects of care is highly influential on outcome. The management of sedation plays a major role in the care of mechanically ventilated patients.[@R2] While necessary to relieve pain and anxiety and improve tolerance of mechanical ventilation, sedatives have adverse effects on important patient-centred outcomes, such as lengths of stay, delirium and mortality.[@R3] Present guidelines recommend that sedatives be titrated to achieve light, as opposed to deep, levels of sedation.[@R2]

Despite these recommendations, deep sedation in the intensive care unit (ICU) is common. Specifically, early deep sedation (ie, during the first 48 hours following initiation of mechanical ventilation) occurs in up to 76% of patients.[@R5] An emerging body of research suggests that the level of sedation during this early time period is an independent predictor of patient outcomes.[@R7] However, the bulk of prior sedation research has not been devoted to this initial early period, often not enrolling patients until after 48 hours of mechanical ventilation.[@R6] While the available evidence supports maintenance of early light sedation, the strength of the association remains unclear.

There have been no systematic reviews on the impact of early sedation on clinical outcomes. An important next step for investigating early sedation practices is to analyse the world literature to ascertain the true impact of early sedation. In this systematic review, we seek to (1) describe the state of global literature focusing on early sedation; and (2) quantify the impact of early sedation depth on patient-centred outcomes. We hypothesise that deep sedation in the 48 hours period following initiation of mechanical ventilation will be associated with increased mortality and longer lengths of stay.

Methods and analysis {#s2}
====================

Protocol and registration {#s2a}
-------------------------

This systematic review protocol is prepared in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) statement (see online [supplementary material 1](#SP1){ref-type="supplementary-material"}).[@R9] The final results will be reported according to the PRISMA statement and the Meta-analysis of Observational Studies in Epidemiology guidelines.[@R11] Any deviation from the protocol will be reported with the final results, along with a rationale for protocol deviation. This study will be conducted starting in February 2017 with an intended completion date in May 2017. This systematic review has been registered in the international prospective register of systematic reviews (PROSPERO \#CRD42017057264).
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###### Supplementary material 1

Search for and identification of studies {#s2b}
----------------------------------------

An electronic search will include the following databases: MEDLINE, Embase, Scopus, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews and Effects, and Cochrane Database of Systematic Reviews. The search terms include the concepts of mechanical ventilation, sedation depth, critical illness and outcome measures (including mortality, delirium, length of stay, tracheostomy, and time ventilated). These strategies were established using a combination of standardised terms and keywords. The fully reproducible search strategy is provided in online [supplementary material 2](#SP2){ref-type="supplementary-material"}. The search was designed in cooperation with a medical librarian, who performed the electronic search.
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###### Supplementary material 2

The reference lists of the articles selected for inclusion will be manually screened to identify additional studies. To identify potential unpublished data, abstracts from the following meetings (from 2010 to 2017) will be manually searched: Society of Critical Care Medicine, European Society of Intensive Care Medicine, International Symposium on Intensive Care and Emergency Medicine, American Thoracic Society, Society for Academic Emergency Medicine, Pharmacotherapy, American Society of Anesthesiologists, European Society of Anaesthesiology, International Anesthesia Research Society, Trauma, Critical Care & Acute Care Surgery, American Association for the Surgery of Trauma, and the Eastern Association for the Surgery of Trauma. An online search for details of clinical trials registration (ClinicalTrials.gov) will also be conducted to identify completed, but not yet published, clinical studies. The principal investigators of published and unpublished studies will also be contacted as needed for clarification of potential data for inclusion.

Eligibility criteria {#s2c}
--------------------

Studies will be eligible regardless of language and will include adult patients receiving invasive positive pressure ventilation. Randomised controlled trials (RCTs), as well as non-randomised studies (prospective and retrospective cohort analyses, cross-sectional studies, before-after trials), will be included. Non-randomised studies will be included for the following reasons: (1) a likelihood that the question of interest may not be investigated strictly with RCTs secondary to a lack of existing randomised trials; (2) to provide an explicit evaluation of strengths and weaknesses of the current literature; (3) to assess evidence of effects (benefit and harm); and (4) to provide evidence for the undertaking of randomised trials. Papers that are reviews, correspondences, editorials and non-human studies will be excluded. Eligibility criteria are listed in [table 1](#T1){ref-type="table"}.

###### 

Eligibility criteria for inclusion in systematic review

  -----------------------------------------------------------------------------------
                       Inclusion criteria                       Exclusion criteria
  -------------------- ---------------------------------------- ---------------------
  Population           Age ≥18 years                            Age \<18 years

  Intervention         Invasive positive pressure ventilation   Chronic ventilation

  Reference standard   Objective measure of sedation depth      None

  Outcomes             Mortality\                               None
                       Hospital length of stay\                 
                       Intensive care unit length of stay\      
                       Time to extubation\                      
                       Delirium\                                
                       Incidence of tracheostomy                

  Study design         Randomised controlled trials\            Correspondences\
                       Prospective cohort studies\              Editorials\
                       Retrospective cohort studies\            Non-human studies
                       Cross-sectional studies\                 
                       Before-after trials                      
  -----------------------------------------------------------------------------------

The intervention will be the sedation provided during the first 48 hours of mechanical ventilation. The comparison will be sedation depth (light sedation vs deep sedation). Eligible studies must report some objective measure of sedation depth, such as the Richmond Agitation-Sedation Scale or the Glasgow Coma Scale. The clinical outcomes will be assessed according to sedation depth. These include mortality, delirium, ventilator-free days, hospital and ICU lengths of stay, and incidence of tracheostomy. The drugs used for early sedation will also be qualitatively reported, as will the study location (ie, ICU, emergency department). If there is a relative paucity of data describing early sedation, we will also qualitatively report the sedation provided at trial enrolment for RCTs. Similarly, we will report the depth of sedation at the time of trial enrolment for RCTs.

Study selection and data abstraction {#s2d}
------------------------------------

Two independent reviewers will screen titles and abstracts of identified studies for eligibility. After this relevance screen, the two reviewers will compare their included studies to determine if disagreement exists. In cases of disagreement, the opinion of a third reviewer will be sought and a consensus will be reached. Full-text articles will then be obtained and these manuscripts will be reviewed for potential inclusion.

The same two reviewers will extract data using standardised forms. The following data on study characteristics will be collected and placed in a table: author, year of publication, study design, number of patients included, characteristics of the patient population, sedation data, study quality, risk of bias and outcomes. We will include pertinent study-specific comments in the table as needed.

Assessment of study quality {#s2e}
---------------------------

We will assess quality of randomised clinical trials using the Cochrane Collaboration's tool for assessing the risk of bias in clinical trials and report a summary assessment for the risk of bias for each studied outcome.[@R13] For studies of observational design, quality will be assessed with the Newcastle Ottawa Scale, assigning a maximum of nine points. Five or fewer points will indicate a high risk of bias.[@R14]

Assessment of publication bias {#s2f}
------------------------------

A graphical display (funnel plot) of the size of the treatment effect against the precision of the trial will be used to evaluate for potential publication bias.

Strategy for data synthesis {#s2g}
---------------------------

We will provide a comprehensive narrative synthesis and qualitative analysis of the data, structured around outcomes related to sedation. After conducting the systematic review, if the data can be pooled, we will use a meta-analytic approach to quantitatively analyse the data. A random-effects model will be used to calculate pooled effect sizes and corresponding 95% CIs between deep and light sedation groups. ORs will be calculated for binary data, such as mortality comparisons. Continuous outcomes will be reported as mean difference, and overall effect estimates will be generated using a Z test and presented as mean differences. A p value of \<0.05 will be considered statistically significant.

Heterogeneity between studies will be assessed using the I^2^ statistic, which will be reported as a point estimate with 95% CIs. We will interpret this statistic using suggested thresholds for low (25%--49%), moderate (50%--74%) and high (≥75%) values.[@R15]

We will perform sensitivity and subgroup analyses if the systematic review suggests that this is feasible and warranted to explore heterogeneity between studies.

Ethics and dissemination {#s3}
========================

As this is a systematic review of completed studies, no ethical approval will be required. Results from this systematic review will be submitted for publication in peer-reviewed journals and will be presented at national meetings.

This study will refine the understanding of the impact of early sedation practices and inform healthcare workers providing care to mechanically ventilated patients. We anticipate that this information will improve the postintubation care received by mechanically ventilated patients.

Over the past decade, there has been an increasing recognition that early advanced care has significant impact on patient outcome during critical illness. This concept has been shown to be true with regard to antibiotics in sepsis, lung protective ventilation in respiratory failure and reperfusion therapy in cerebrovascular accident.[@R16] However, there has not been a similar focus on early sedation care for patients treated with mechanical ventilation.

This systematic review will provide a complete synopsis of the world's literature examining the impact of early deep sedation on patient outcomes, including mortality and lengths of stay. We will assess the cohort of studies for study quality, publication bias and heterogeneity, and determine if a meta-analysis is appropriate. We expect to find that early deep sedation is associated with worse mortality, longer lengths of stay and greater ventilation duration. Furthermore, we will identify knowledge gaps in the literature as future research targets.

In conclusion, this systemic review will aim to characterise and quantify the impact of early sedation on patient important outcomes. We hope this study yields additional evidence to guide clinical practice in mechanically ventilated patients, as well as targets for future investigation.
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